Suppr超能文献

唐氏综合征患者淋巴细胞中某些嘌呤代谢酶的水平。

Levels of some purine metabolizing enzymes in lymphocytes from patients with Down's syndrome.

作者信息

Puukka R, Puukka M, Perkkilä L, Kouvalainen K

出版信息

Biochem Med Metab Biol. 1986 Aug;36(1):45-50. doi: 10.1016/0885-4505(86)90105-2.

Abstract

The activities of a number of purine metabolizing enzymes of erythrocytes and lymphocytes were determined in 18 subjects with Down's syndrome and in 18 age- and sex-matched control subjects. An increase of adenosine deaminase activity (adenosine or deoxyadenosine as substrates) was found in erythrocytes (P less than 0.001) as well as in lymphocytes (P less than 0.001) of Down's syndrome subjects compared to controls. The purine nucleoside phosphorylase activities in lymphocytes and plasma urate concentrations were also significantly higher in Down's syndrome subjects than in controls (P less than 0.001 and less than 0.02, respectively). Adenine phosphoribosyltransferase activities and hypoxanthine-guanine phosphoribosyltransferase activities in lymphocytes were identical in the two groups. In all subjects studied there were positive correlations between the erythrocyte adenosine deaminase activities, lymphocyte adenosine deaminase or deoxyadenosine activities, and plasma urate concentrations (P less than 0.05 in all cases), and between lymphocyte nucleoside phosphorylase and lymphocyte adenosine deaminase or deoxyadenosine deaminase activities (P less than 0.01 and less than 0.05, respectively). The results suggest that increased activities of some purine metabolizing enzymes found in both erythrocytes and lymphocytes may contribute to increased purine degradation and hyperuricemia in subjects with Down's syndrome. In addition, the increased adenosine deaminase and nucleoside phosphorylase activities may be related to the immunological dysfunction found in subjects with Down's syndrome.

摘要

测定了18名唐氏综合征患者以及18名年龄和性别匹配的对照者红细胞和淋巴细胞中多种嘌呤代谢酶的活性。与对照组相比,唐氏综合征患者红细胞(P<0.001)和淋巴细胞(P<0.001)中的腺苷脱氨酶活性(以腺苷或脱氧腺苷为底物)均增加。唐氏综合征患者淋巴细胞中的嘌呤核苷磷酸化酶活性和血浆尿酸盐浓度也显著高于对照组(分别为P<0.001和<0.02)。两组淋巴细胞中的腺嘌呤磷酸核糖转移酶活性和次黄嘌呤-鸟嘌呤磷酸核糖转移酶活性相同。在所有研究对象中,红细胞腺苷脱氨酶活性、淋巴细胞腺苷脱氨酶或脱氧腺苷活性与血浆尿酸盐浓度之间均呈正相关(所有情况均为P<0.05),淋巴细胞核苷磷酸化酶与淋巴细胞腺苷脱氨酶或脱氧腺苷脱氨酶活性之间也呈正相关(分别为P<0.01和<0.05)。结果表明,红细胞和淋巴细胞中某些嘌呤代谢酶活性的增加可能导致唐氏综合征患者嘌呤降解增加和高尿酸血症。此外,腺苷脱氨酶和核苷磷酸化酶活性的增加可能与唐氏综合征患者的免疫功能障碍有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验